Medwatch
Found 6 free book(s)
www.fda.gov/medwatch
www.accessdata.fda.govNDA 211950 Page 9 . Step 12 . Hold the syringe barrel with the needle pointing up. Expel air bubbles and excess drug by slowly sliding the white plunger handle so that the plunger
URGENT: Medical Device Recall
www.philips.comFDA’s MedWatch Adverse Event Reporting program either online, or by regular mail or fax. This notice has been reported to the appropriate Regulatory Agencies. Philips regrets any inconveniences caused by this problem. Sincerely, Rodney Mell Head of Quality and Regulatory Philips Respironics - Sleep & Respiratory Care
HIGHLIGHTS OF PRESCRIBING INFORMATION o For patients …
docs.boehringer-ingelheim.comReduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation For patients with creatinine clearance (CrCl) >30 mL/min, the recommended dose of …
NIOSH List of Antineoplastic and Other Hazardous Drugs in ...
www.cdc.govThe National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occu-pational Exposures to Antineoplastic and Other Hazardous …
Tecentriq Prescribing Information - Genentech
www.gene.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Urothelial Carcinoma TECENTRIQ is indicated for the treatment of adult patients with locally advanced or metastatic
XOLAIR Prescribing Information - Genentech
www.gene.com3 FULL PRESCRIBING INFORMATION WARNING: ANAPHYLAXIS Anaphylaxis presenting as bronchospasm, hypotension, syncope, urticaria, and/or angioedema of the throat or tongue, has been reported to occur after administration of